In vitro evaluation of a novel process for reducing bacterial contamination of environmental surfaces

被引:20
作者
Baxa, Dwayne [1 ]
Shetron-Rama, Lynne [2 ]
Golembieski, Marisabel [1 ]
Golembieski, Michelle [1 ]
Jain, Susmita [2 ]
Gordon, Milana [1 ]
Zervos, Marcus [1 ]
机构
[1] Henry Ford Hosp, Dept Infect Dis Res, Detroit, MI 48202 USA
[2] Eastern Michigan Univ, Dept Clin Lab Sci, Ypsilanti, MI 48197 USA
关键词
Antimicrobial surfactant; methicillin-resistant Staphylococcus aureus; Pseudomonas aeruginosa; Escherichia coli; infection control; RESISTANT STAPHYLOCOCCUS-AUREUS; NOSOCOMIAL INFECTIONS; COLONIZATION; COSTS; RISK;
D O I
10.1016/j.ajic.2010.10.015
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Disinfection of contaminated surfaces is an integral and challenging aspect of infection prevention. We evaluated the ability of Goldshield 5 (GS; NBS Technology, Laurelton, NY), an antimicrobial surfactant that coats surfaces with covalently bound octadecyldimethylammonium ions, to reduce the bacterial burden on contaminated surfaces. Methods: We tested the GS product for inhibitory activity against patient isolates of methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa (PA), and Escherichia coli (EC) on fabric according to the garment industry standard American Association of Textile Chemists and Colorists 100 protocol. We also tested the product for activity against these same isolates in carrier tests with a modified Association of Official Analytical Chemists use-dilution method. Results: On fabric, viability of bacterial isolates was inhibited for 14 days. GS also reduced recovery of viable MRSA, PA, and EC from Formica and stainless steel carriers treated with the product. Conclusion: Our results demonstrate that GS has inhibitory activity and potential utility as part of an infection control process.
引用
收藏
页码:483 / 487
页数:5
相关论文
共 12 条
[1]  
*AM ASS TEXT CHEM, 2002, 1001999 AATCC
[2]   National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004 [J].
Cardo, D ;
Horan, T ;
Andrus, M ;
Dembinski, M ;
Edwards, J ;
Peavy, G ;
Tolson, J ;
Wagner, D .
AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) :470-485
[3]   The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs [J].
Cosgrove, SE .
CLINICAL INFECTIOUS DISEASES, 2006, 42 :S82-S89
[4]   Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection [J].
Davis, KA ;
Stewart, JJ ;
Crouch, HK ;
Florez, CE ;
Hospenthal, DR .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (06) :776-782
[5]   Transfer of vancomycin-resistant enterococci via health care worker hands [J].
Duckro, AN ;
Blom, DW ;
Lyle, EA ;
Weinstein, RA ;
Hayden, MK .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (03) :302-307
[6]   Risk of acquiring antibiotic-resistant bacteria from prior room occupants [J].
Huang, Susan S. ;
Datta, Rupak ;
Platt, Richard .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (18) :1945-1951
[7]  
International Organization for Standardization, 1999, 109935 ISO
[8]   Colonization pressure and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit [J].
Merrer, J ;
Santoli, F ;
Appéré-De Vecchi, C ;
Tran, B ;
De Jonghe, B ;
Outin, H .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2000, 21 (11) :718-723
[9]   CHARACTERIZATION OF THE EXTERNAL SURFACES OF PSEUDOMONAS-AERUGINOSA ISOLATED FROM HUMAN BLOOD AND RESPIRATORY-TRACT [J].
MISUMI, H ;
UMEDA, A ;
EGUCHI, K ;
OKADA, K ;
SAWAE, Y ;
NIHO, Y ;
AMAKO, K .
JOURNAL OF MEDICAL MICROBIOLOGY, 1994, 40 (04) :282-287
[10]   The use of economic modeling to determine the hospital costs associated with nosocomial infections [J].
Roberts, RR ;
Scott, RD ;
Cordell, R ;
Solomon, SL ;
Steele, L ;
Kampe, LM ;
Trick, WE ;
Weinstein, RA .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (11) :1424-1432